These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 12077955)
41. Inappropriate use of central venous catheters results in one in ten complications. Beutler JM AANA J; 1989 Oct; 57(5):389-90. PubMed ID: 2603620 [No Abstract] [Full Text] [Related]
42. Minimising central venous catheter-associated bloodstream infections--'Matching Michigan' in England. Richardson A Nurs Crit Care; 2009; 14(3):105-6. PubMed ID: 19366405 [No Abstract] [Full Text] [Related]
43. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005 [TBL] [Abstract][Full Text] [Related]
44. Formation of a calcified "cast" in a long-term indwelling central venous catheter: a case report. Hughes DB; Ullery BW; Spigland N J Pediatr Surg; 2006 Nov; 41(11):1927-9. PubMed ID: 17101373 [TBL] [Abstract][Full Text] [Related]
45. [Prevention of central vein catheter infections]. Ala-Kokko T; Syrjälä H Duodecim; 2005; 121(15):1689-93. PubMed ID: 16211844 [No Abstract] [Full Text] [Related]
46. Criteria for use of total parenteral nutrition administered by a central venous catheter in adults. Presbyterian Hospital, Albuquerque, New Mexico. D'Angio RG; Dutro M Hosp Pharm; 1992 Nov; 27(11):963-7, 970. PubMed ID: 10122040 [TBL] [Abstract][Full Text] [Related]
47. Are antiseptic-coated central venous catheters effective in a real-world setting? Borschel DM; Chenoweth CE; Kaufman SR; Hyde KV; VanDerElzen KA; Raghunathan TE; Collins CD; Saint S Am J Infect Control; 2006 Aug; 34(6):388-93. PubMed ID: 16877109 [TBL] [Abstract][Full Text] [Related]
48. Prospective study of peripheral arterial catheter infection and comparison with concurrently sited central venous catheters. Koh DB; Gowardman JR; Rickard CM; Robertson IK; Brown A Crit Care Med; 2008 Feb; 36(2):397-402. PubMed ID: 18216598 [TBL] [Abstract][Full Text] [Related]
49. Set a goal of zero central line and VAP infections. Determining what is really preventable. Hosp Peer Rev; 2008 Jan; 33(1):4-5. PubMed ID: 18402274 [No Abstract] [Full Text] [Related]
50. Fatal central venous catheter-related infection in haemophilia. Crary SE; Buchanan GR; Journeycake JM Haemophilia; 2006 Mar; 12(2):183-6. PubMed ID: 16476095 [TBL] [Abstract][Full Text] [Related]
51. Prospective nonrandomized trial of silver impregnated cuff central lines. Alderman RL; Sugarbaker PH Int Surg; 2005; 90(4):219-22. PubMed ID: 16548318 [TBL] [Abstract][Full Text] [Related]
52. [Prevention of infectious complications of central venous catheters in children]. Uher M; Pisarcíková M; Kurák M; Cernáková A; Topolský I Klin Mikrobiol Infekc Lek; 2004 Oct; 10(5):214-7. PubMed ID: 15558449 [TBL] [Abstract][Full Text] [Related]
56. [Infections related to central venous catheters. Value of a more anatomical approach to the subclavian vein]. Aveline C; Greffe B Presse Med; 1996 Jan; 25(2):84. PubMed ID: 8745731 [No Abstract] [Full Text] [Related]
57. Central venous catheters and sepsis in patients with quadriplegia. Walker JB; Gu H; Harris M N Engl J Med; 1992 Sep; 327(10):735-6. PubMed ID: 1495539 [No Abstract] [Full Text] [Related]
58. Clinical predictors of infection of central venous catheters used for total parenteral nutrition. Segura M; Sitges-Serra A Infect Control Hosp Epidemiol; 1991 Jul; 12(7):407-11. PubMed ID: 1918885 [No Abstract] [Full Text] [Related]